Nkarta Inc (NKTX)
Healthcare
Biotechnology
2.10 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Nkarta Inc (NKTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 84.5% of the shares are freely tradable; institutional investors hold 80.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
80.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
4.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
84.5%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
72Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 15.10 | 10,805,129 | +0.0 | 03/31/2026 |
| BlackRock Inc | 6.30 | 4,508,473 | +9.6 | 03/31/2026 |
| NEA Management Company, LLC | 4.99 | 3,568,781 | +0.0 | 03/31/2026 |
| Samsara BioCapital, LLC | 4.90 | 3,507,666 | +0.0 | 03/31/2026 |
| SR ONE CAPITAL MANAGEMENT, LP | 4.66 | 3,333,333 | +0.0 | 12/31/2025 |
| GSK PLC | 4.40 | 3,150,732 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 3.63 | 2,597,370 | +4.2 | 12/31/2025 |
| Monaco Asset Management | 3.52 | 2,521,932 | -1.0 | 03/31/2026 |
| Alyeska Investment Group, L.P. | 2.91 | 2,084,840 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 2.86 | 2,047,376 | +110.6 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.